Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of azithromycin 250 mg capsules vs ZITHROMAX 250 in healthy Thai volunteers under fasting conditions
TCTR20170110001Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of azithromycin (2 arms), sponsored by Bio-innova. Planned start Jan 2017; status: not yet recruiting.
02
Drugs
azithromycin
Beyond the preview
Go deeper on TCTR20170110001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170110001.